Latest Period
Q2 2026
Security Snapshot
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) Institutional Ownership
CUSIP: 552641102
13F Institutional Holders and Ownership History from Q3 2022 to Q2 2026
Institutions Reporting
36
Shares (Excl. Options)
13,524,351
Price
$1.44
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- MAIA on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 13,524,351
- Total 13F value
- $19,435,481
- Portfolio coverage rank
- 0%
- Share change
- +372,381
- Value change
- +$544,005
- Number of holders
- 36
- Shares outstanding
- 61,853,980
- SEC-reported price per share
- $1.24
- Insider filing price
- $1.24
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 552641102.
- 36 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 32 to 36 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $18,402,624 to $19,435,481.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 36 institutions filings for Q2 2026.
Security key
552641102
Latest holder period
Q2 2026
13F holders
36
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
MAIA full holder history
MAIA Biotechnology, Inc. SEC filings
MAIA Biotechnology, Inc. company facts
MAIA Biotechnology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 552641102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
MAIA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vitoc Vlad | 9.7% | $4,307,914 | 3,846,352 | Vlad Vitoc | 21 Nov 2025 | |||
| Solas Capital Management, LLC | 4.9% | -31% | $4,303,800 | -$1,797,946 | 3,030,845 | -29% | Solas Capital Management, LLC | 30 Jun 2026 |
| FGMK Business Holdings, LLC | 10% | $6,068,078 | 2,889,561 | FGMK Business Holdings, LLC | 14 Sep 2024 | |||
| Gryaznov Sergei | 4.1% | $2,394,242 | 1,140,115 | Sergei M. Gryaznov | 31 Dec 2023 |
As of 30 Jun 2026, 36 institutional investors reported holding 13,524,351 shares of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA). This represents 22% of the company’s total 61,853,980 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
22%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Solas Capital Management, LLC | 4.9% | 3,030,845 | -29% | 2.3% | $4,364,417 |
| Alyeska Investment Group, L.P. | 4% | 2,500,000 | 0% | 0.01% | $3,600,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 2,413,270 | +16% | 0% | $3,475,109 |
| 683 Capital Management, LLC | 1.7% | 1,066,666 | 0% | 0.14% | $1,535,999 |
| Centric Wealth Management | 1.3% | 796,723 | 0% | 0.17% | $1,107,445 |
| Cable Car Capital, LP | 0.83% | 514,583 | -21% | 0.02% | $741,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.82% | 504,380 | +40% | 0% | $726,568 |
| Bleichroeder LP | 0.81% | 500,000 | 0% | 0.13% | $720,000 |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 415,700 | 0% | $598,608 | |
| BlackRock, Inc. | 0.65% | 403,011 | +215% | 0% | $580,335 |
| VANGUARD FIDUCIARY TRUST CO | 0.54% | 336,688 | +69% | 0% | $484,831 |
| STATE STREET CORP | 0.33% | 201,750 | +45% | 0% | $290,520 |
| Bleakley Financial Group, LLC | 0.29% | 181,623 | 0% | $261,537 | |
| NORTHERN TRUST CORP | 0.2% | 125,171 | +138% | 0% | $180,246 |
| MORGAN STANLEY | 0.17% | 104,017 | +651% | 0% | $149,784 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.12% | 76,000 | +111% | 0% | $109,440 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 50,383 | 0% | $72,552 | |
| ENVESTNET ASSET MANAGEMENT INC | 0.07% | 44,347 | 0% | $63,860 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | 35,223 | 0% | $50,721 | |
| PVG ASSET MANAGEMENT CORP | 0.06% | 34,135 | 0% | 0.03% | $49,154 |
| UBS Group AG | 0.05% | 33,435 | -36% | 0% | $48,147 |
| CITADEL ADVISORS LLC | 0.04% | 24,890 | 0% | $35,842 | |
| Cetera Investment Advisers | 0.04% | 22,748 | 0% | $32,757 | |
| LAZARI CAPITAL MANAGEMENT, INC. | 0.04% | 21,750 | 0.01% | $31,320 | |
| Atria Investments, Inc | 0.03% | 21,100 | 0% | $30,384 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
16
Latest
Q2 2026
Rows shown
1-16 of 16
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 13,524,351 | $19,435,481 | +$544,005 | $1.44 | 36 |
| 2026 Q1 | 13,151,970 | $18,402,624 | +$13,290,851 | $1.40 | 32 |
| 2025 Q4 | 2,516,804 | $4,090,881 | +$210,647 | $1.53 | 26 |
| 2025 Q3 | 2,373,804 | $3,487,006 | +$129,244 | $1.54 | 19 |
| 2025 Q2 | 2,284,355 | $3,952,129 | +$1,392,212 | $1.80 | 20 |
| 2025 Q1 | 1,477,270 | $2,261,254 | +$114,552 | $1.53 | 20 |
| 2024 Q4 | 1,390,935 | $2,754,258 | -$193,537 | $1.98 | 20 |
| 2024 Q3 | 1,467,276 | $4,148,452 | -$930,566 | $2.81 | 17 |
| 2024 Q2 | 1,788,020 | $6,092,876 | +$3,928,913 | $3.42 | 20 |
| 2024 Q1 | 660,884 | $1,502,744 | -$141,291 | $2.20 | 19 |
| 2023 Q4 | 803,162 | $957,759 | +$550,428 | $1.17 | 21 |
| 2023 Q3 | 318,278 | $699,643 | -$8,833 | $2.20 | 13 |
| 2023 Q2 | 321,911 | $709,089 | +$545,884 | $2.20 | 11 |
| 2023 Q1 | 71,531 | $246,685 | +$83,630 | $3.45 | 6 |
| 2022 Q4 | 297,126 | $1,043,412 | +$236,126 | $3.51 | 6 |
| 2022 Q3 | 231,277 | $763,000 | +$763,000 | $3.30 | 7 |